The Next “Surge”: Drug Shortages
This article was originally published in RPM Report
Executive Summary
President Obama’s drug shortage executive order puts drug shortages in some pretty heady company: alongside mortgage relief and jobs for veterans to rescue the economy, and invoking the metaphor of turning points in the Iraq and Afghanistan wars. The order itself won’t change much.
You may also be interested in...
The End of an Era: Lipitor, Blockbuster Drugs and the Waxman/Hatch Model
Pfizer’s Lipitor goes generic—albeit with some decidedly unusual wrinkles. The biggest generic launch in history is a good moment to take stock of the transition away from the blockbuster model. The reaction to the milestone suggests that the industry’s critics may be having a harder time letting go of the old model than industry is.
Early Notification Legislation: What The Bills Say
Both houses have introduced legislation to require manufacturers to notify FDA in advance of planned interruptions or as soon as possible when facing a shortage. Here’s a look at the details.
Drug Shortage Could Be Addressed By ‘Resilience Rating’ From Private Entity Under HHS Plan
US HHS is proposing a public-private partnership to assign ratings to manufacturers based on quality/resilience of supply, tied to a purchasing incentive program for providers. The non-agency approach may be key to overcoming industry and political objections.